Gabrielle Pryce is a Strategy Director at Klick Health, bringing over 14 years of cross sector experience across pharma, life sciences, and public policy. She specialises in global-to-local commercial strategy across complex, highly regulated healthcare markets, partnering with senior leadership to shape portfolio strategy and deliver commercially impactful outcomes across EMEA and global markets.
Her work focuses on designing AI-enabled operating models, enterprise workflows, and next-generation campaign systems that improve speed, compliance, and performance at scale. Known for bridging strategy and execution, she aligns global vision with local market realities to unlock growth across diverse therapy areas and culturally complex environments. Her career began in genetics, where she contributed to early precision medicine and predictive testing programmes, and has since focused on rare and
complex diseases.
Operating at the intersection of healthcare, technology, and institutional systems, Gabrielle brings a rare fluency in navigating regulatory, cultural, and policy-driven environments. She is recognised for building scalable, future-ready models that amplify human expertise, enabling organisations to adapt faster, expand across markets, and deliver sustained impact in some of the world’s most demanding healthcare landscapes.
